Previous close | 2.8300 |
Open | 2.9900 |
Bid | 2.5400 |
Ask | 3.1500 |
Strike | 28.00 |
Expiry date | 2025-06-20 |
Day's range | 2.9800 - 3.0600 |
Contract range | N/A |
Volume | |
Open interest | 7.15k |
Andrew Baum, the prominent Wall Street drug company analyst will be the pharma firm’s chief strategy and innovation officer.
Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
The pharmaceutical company posts a first-quarter loss of €1.31 a share, a swing from year-earlier profit of €2.05.